Novel Cell-Based Therapies
Treating Solid Tumors
NK Bioscience is an early-stage company developing novel NK cell-based therapies for the treatment of solid tumors. The NK cells developed by us continue to grow and kill metastatic tumor cells in the presence of high levels of immunosuppressive factors.
Our observations show that, in cell culture, normal NK-cells kill melanoma cells due to the lack of immunosuppressant factors. However, when we add those factors to the medium, normal NK-cells are completely inactive against the melanoma cells.
We are pioneering next-generation cancer treatments through precision science, innovative research, and a commitment to transforming patient outcomes worldwide.
NK Bioscience is an early-stage company developing novel NK cell-based therapies for the treatment of solid tumors. The NK cells developed by us continue to grow and kill metastatic tumor cells in the presence of high levels of immunosuppressive factors.
NK Bioscience is an early-stage company developing novel NK
cell-based therapies for the treatment of solid tumors. The NK cells developed by us continue to grow and kill metastatic tumor cells in the presence of high levels of immunosuppressive factors.
